000 01199 a2200361 4500
005 20250513205244.0
264 0 _c20000511
008 200005s 0 0 eng d
022 _a0312-5963
024 7 _a10.2165/00003088-200038030-00002
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTod, M
245 0 0 _aClinical pharmacokinetics and pharmacodynamics of isepamicin.
_h[electronic resource]
260 _bClinical pharmacokinetics
_cMar 2000
300 _a205-23 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdult
650 0 4 _aAging
_xmetabolism
650 0 4 _aAnimals
650 0 4 _aAnti-Bacterial Agents
_xadverse effects
650 0 4 _aChild
650 0 4 _aGentamicins
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aInfant, Newborn
650 0 4 _aInjections, Intramuscular
650 0 4 _aInjections, Intravenous
650 0 4 _aMicrobial Sensitivity Tests
650 0 4 _aTissue Distribution
700 1 _aPadoin, C
700 1 _aPetitjean, O
773 0 _tClinical pharmacokinetics
_gvol. 38
_gno. 3
_gp. 205-23
856 4 0 _uhttps://doi.org/10.2165/00003088-200038030-00002
_zAvailable from publisher's website
999 _c10702894
_d10702894